Aventis, Baxter Renew Battle Over Hemophilia Drug
Aventis Pharma SA has refiled a lawsuit claiming Baxter Healthcare Corp. markets a drug that infringes its patent related to Factor VIII, the protein necessary to form blood clots....To view the full article, register now.
Already a subscriber? Click here to view full article